| Palladium‐Catalyzed Oxidative Double C H Functionalization/Carbonylation for the Synthesis of Xanthones H Zhang, R Shi, P Gan, C Liu, A Ding, Q Wang, A Lei Angewandte Chemie International Edition 21 (51), 5204-5207, 2012 | 158 | 2012 |
| Tri-, Tetra- and Pentamers of 9,9′-Spirobifluorenes through Full ortho-Linkage: High Triplet-Energy Pure Hydrocarbon Host for Blue Phosphorescent Emitter C Fan, Y Chen, P Gan, C Yang, C Zhong, J Qin, D Ma Organic Letters 12 (24), 5648-5651, 2010 | 80 | 2010 |
| (E)-α, β-unsaturated amides from tertiary amines, olefins and CO via Pd/Cu-catalyzed aerobic oxidative N-dealkylation R Shi, H Zhang, L Lu, P Gan, Y Sha, H Zhang, Q Liu, M Beller, A Lei Chemical communications 51 (15), 3247-3250, 2015 | 71 | 2015 |
| Pyrone Diels–Alder Routes to Indolines and Hydroindolines: Syntheses of Gracilamine, Mesembrine, and Δ7‐Mesembrenone P Gan, MW Smith, NR Braffman, SA Snyder Angewandte Chemie International Edition 55 (11), 3625-3630, 2016 | 70 | 2016 |
| Simple bipolar molecules constructed from biphenyl moieties as host materials for deep‐blue phosphorescent organic light‐emitting diodes C Fan, F Zhao, P Gan, S Yang, T Liu, C Zhong, D Ma, J Qin, C Yang Chemistry–A European Journal 18 (18), 5510-5514, 2012 | 66 | 2012 |
| Total Synthesis of the Caged Indole Alkaloid Arboridinine Enabled by aza-Prins and Metal-Mediated Cyclizations P Gan, J Pitzen, P Qu, SA Snyder Journal of the American Chemical Society 140 (3), 919-925, 2018 | 55 | 2018 |
| FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS X Wang, PN Carlsen, P Gan, G Hoang, Y Li, C Qi, L Wu, W Yao, Z Yu, ... US Patent US 2020/0031835 A1, 2020 | 13 | 2020 |
| IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS X Wang, P Gan, H Han, T Huang, MS McCammant, C Qi, D Qian, L Wu, ... US Patent US 2019/0292188A1, 2019 | 12 | 2019 |
| Imidazopyrimidines and triazolopyrimidines as a2a/a2b inhibitors X Wang, P Gan, T Huang, C Qi, DQ Qian, L Wu, W Yao, Z Yu, F Zhang, ... US Patent 11,673,894, 2023 | 6 | 2023 |
| Tricyclic compounds as inhibitors of kras X Wang, W Zhu, J Yang, A Sokolsky, C He, Z Li, C Qi, Y Li, P Gan, ... US Patent App. 17/144,374, 2021 | 5 | 2021 |
| Fused pyrazine derivatives as A2A/A2B inhibitors X Wang, PN Carlsen, P Gan, G Hoang, Y Li, C Qi, L Wu, W Yao, W Zhu US Patent 11,999,740, 2024 | 3 | 2024 |
| Vinyl imidazole compounds as inhibitors of KRAS P Carlsen, X Wang, A Sokolsky, P Gan, R Policarpo, W Yao US Patent 11,999,752, 2024 | 3 | 2024 |
| Fused tricyclic compounds as inhibitors of kras g12v mutants G Li, L Liu, P Gan, C Min, A Sokolsky, X Wang, Q Ye, L Zhao US Patent App. 18/349,606, 2024 | | 2024 |
| Imidazopyrimidines and triazolopyrimidines as a2a/a2b inhibitors X Wang, P Gan, T Huang, C Qi, DQ Qian, L Wu, W Yao, Z Yu, F Zhang, ... US Patent App. 18/300,349, 2023 | | 2023 |
| Imidazopirimidinas y triazolopirimidinas como inhibidores de a2a/a2b (divisional 2020-0441) DQ Qian, P Gan, Z Yu, MS Mccammant, T Huang, H Han, L Wu, W Yao, ... | | 2023 |
| Tricyclic compounds as inhibitors of kras P Gan, J Yang, Y Li, L Zhao, C He, CM Law, X Wang, W Yao US Patent App. 17/810,915, 2023 | | 2023 |
| Derivados de pirazina fusionados como inhibidores de a2a/a2b PN Carlsen, W Zhu, G Hoang, P Gan, Y Li, C Qi, L Wu, W Yao, Z Yu | | 2021 |
| Dérivés de pyrazine fusionnés en tant qu'inhibiteurs d'a2a/a2b PN Carlsen, P Gan, G Hoang, Y Li, C Qi, L Wu, W Yao, Z Yu, W Zhu | | 2021 |
| Fused pyrazine derivatives as a2a/a2b inhibitors G Hoang, X Wang, PN Carlsen, P Gan, Y Li, QI Chao, L Wu, W Yao, Z Yu, ... | | 2021 |
| Derivados de pirazina fusionados como inhibidores de a2a/a2b Z Yu, G Hoang, PN Carlsen, C Qi, W Yao, Y Li, W Zhu, P Gan, L Wu | | 2021 |
